Malignant neoplasm of head of pancreas
ICD-10 C25.0 is a billable code used to indicate a diagnosis of malignant neoplasm of head of pancreas.
Malignant neoplasm of the head of the pancreas is a serious and often fatal condition characterized by the uncontrolled growth of abnormal cells in the pancreatic tissue located at the head of the pancreas. This type of cancer is typically diagnosed at an advanced stage due to its asymptomatic nature in early stages, leading to significant challenges in treatment and management. Symptoms may include jaundice, weight loss, abdominal pain, and changes in stool. The prognosis for patients with pancreatic cancer is generally poor, with a five-year survival rate of less than 10%. Staging is complicated by the lack of early symptoms and the tendency for the cancer to metastasize quickly. The CA 19-9 tumor marker is often elevated in patients with pancreatic cancer and can be used to monitor treatment response and disease progression. However, it is not specific to pancreatic cancer and can be elevated in other conditions, which complicates its use in diagnosis.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with jaundice, weight loss, and abdominal pain; follow-up after chemotherapy.
Ensure accurate staging and documentation of any metastasis.
Endoscopic findings, imaging results, and laboratory tests including CA 19-9 levels.
Evaluation of obstructive jaundice; management of pancreatic insufficiency.
Document any interventions performed, such as stenting or biopsies.
Often performed in conjunction with pancreatic cancer treatment if gallbladder involvement is suspected.
Operative report detailing the procedure and findings.
Ensure that the oncology team is aware of any surgical interventions.
CA 19-9 is a tumor marker that is often elevated in patients with pancreatic cancer. It is used to monitor treatment response and disease progression, but it is not specific to pancreatic cancer and can be elevated in other conditions.
